A Study of IBI110 in Combination With Sintilimab and Chemotherapy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer
Clinical trial NCT05026593 · COMPLETED
Trial details
- NCT number
- NCT05026593
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-07
- Primary completion
- 2023-02-16
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.